Capstone Investment Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,400
Closed -$29K 2115
2024
Q2
$29K Hold
1,400
﹤0.01% 1990
2024
Q1
$26.3K Hold
1,400
﹤0.01% 2249
2023
Q4
$20.2K Sell
1,400
-20,700
-94% -$282K ﹤0.01% 2046
2023
Q3
$384K Buy
22,100
+3,200
+17% +$66.7K ﹤0.01% 1458
2023
Q2
$393K Buy
18,900
+900
+5% +$19.6K ﹤0.01% 1265
2023
Q1
$423K Sell
18,000
-10,600
-37% -$285K ﹤0.01% 1065
2022
Q4
$799K Buy
28,600
+5,700
+25% +$146K 0.01% 1001
2022
Q3
$536K Buy
22,900
+3,700
+19% +$112K ﹤0.01% 1230
2022
Q2
$648K Sell
19,200
-53,800
-74% -$1.88M ﹤0.01% 1164
2022
Q1
$2.55M Buy
73,000
+41,500
+132% +$1.42M 0.01% 945
2021
Q4
$959K Sell
31,500
-1,300
-4% -$42.3K ﹤0.01% 1334
2021
Q3
$1.08M Buy
+32,800
New +$1.05M ﹤0.01% 1380

Other funds holding OGN

Capstone Investment Advisors's OGN Position: Q4 2025 in Review

Capstone Investment Advisors sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 40,980 shares — an estimated $438K sold.

Capstone Investment Advisors first reported a position in OGN in Q3 2021 and held it in 12 quarters. The position peaked at $600K in Q3 2023. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Capstone Investment Advisors reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 40,980 Organon & Co shares in Q4 2025, an estimated $438K.
  • Capstone Investment Advisors first reported a position in Organon & Co in Q3 2021 and held it in 12 quarters.
  • Capstone Investment Advisors's Organon & Co position peaked at $600K in Q3 2023.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Capstone Investment Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.